Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
23.74
-0.75 (-3.06%)
Nov 21, 2024, 3:01 PM EST - Market open
Beam Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 349.64 | 377.71 | 60.92 | 51.84 | 0.02 | 0.02 | Upgrade
|
| Revenue Growth (YoY) | 328.73% | 520.01% | 17.51% | 215916.67% | 33.33% | - | Upgrade
|
| Cost of Revenue | 406.19 | 437.38 | 311.59 | 232.13 | 103.18 | 54.62 | Upgrade
|
| Gross Profit | -56.55 | -59.67 | -250.67 | -180.29 | -103.16 | -54.6 | Upgrade
|
| Selling, General & Admin | 126.12 | 116.81 | 87.81 | 57.22 | 29.61 | 20.55 | Upgrade
|
| Operating Expenses | 126.12 | 116.81 | 87.81 | 57.22 | 29.61 | 20.55 | Upgrade
|
| Operating Income | -182.67 | -176.49 | -338.48 | -237.51 | -132.76 | -75.15 | Upgrade
|
| Interest Expense | - | - | - | -0.01 | - | - | Upgrade
|
| Interest & Investment Income | 50.23 | 46.68 | 15.3 | - | 1.05 | 2.23 | Upgrade
|
| Earnings From Equity Investments | - | - | -25.5 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.5 | 7.5 | 23.9 | -1 | -63.4 | -5.4 | Upgrade
|
| EBT Excluding Unusual Items | -131.94 | -122.31 | -324.78 | -238.52 | -195.11 | -78.33 | Upgrade
|
| Gain (Loss) on Sale of Investments | -13.73 | -18.59 | 20.2 | 17.69 | 0.52 | - | Upgrade
|
| Other Unusual Items | 3.48 | 9.74 | 18.9 | 5.15 | - | - | Upgrade
|
| Pretax Income | -142.19 | -131.16 | -285.68 | -370.64 | -194.59 | -78.33 | Upgrade
|
| Income Tax Expense | 1.41 | 1.37 | 3.41 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -143.59 | -132.53 | -289.09 | -370.64 | -194.59 | -78.33 | Upgrade
|
| Net Income | -143.59 | -132.53 | -289.09 | -370.64 | -194.59 | -78.33 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.28 | 12.71 | Upgrade
|
| Net Income to Common | -143.59 | -132.53 | -289.09 | -370.64 | -195.87 | -91.04 | Upgrade
|
| Shares Outstanding (Basic) | 82 | 77 | 70 | 64 | 47 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 82 | 77 | 70 | 64 | 47 | 6 | Upgrade
|
| Shares Change (YoY) | 9.66% | 10.19% | 9.01% | 37.43% | 621.24% | 123.90% | Upgrade
|
| EPS (Basic) | -1.75 | -1.72 | -4.13 | -5.77 | -4.19 | -14.05 | Upgrade
|
| EPS (Diluted) | -1.75 | -1.72 | -4.13 | -5.77 | -4.19 | -14.05 | Upgrade
|
| Free Cash Flow | -145.37 | -182.93 | -26.42 | -113.08 | -112.1 | -84.52 | Upgrade
|
| Free Cash Flow Per Share | -1.78 | -2.37 | -0.38 | -1.76 | -2.40 | -13.04 | Upgrade
|
| Gross Margin | -16.17% | -15.80% | - | - | - | - | Upgrade
|
| Operating Margin | -52.25% | -46.73% | -555.61% | -458.13% | -553166.67% | -417522.22% | Upgrade
|
| Profit Margin | -41.07% | -35.09% | -474.54% | -714.91% | -816120.83% | -505777.78% | Upgrade
|
| Free Cash Flow Margin | -41.58% | -48.43% | -43.37% | -218.11% | -467075.00% | -469561.11% | Upgrade
|
| EBITDA | -160.83 | -156.47 | -324.33 | -230.06 | -128.03 | -71.65 | Upgrade
|
| EBITDA Margin | -46.00% | -41.43% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 21.84 | 20.01 | 14.15 | 7.45 | 4.74 | 3.5 | Upgrade
|
| EBIT | -182.67 | -176.49 | -338.48 | -237.51 | -132.76 | -75.15 | Upgrade
|
| EBIT Margin | -52.25% | -46.73% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.